{"id":9455,"date":"2026-05-21T16:15:00","date_gmt":"2026-05-21T14:15:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=d8cb441b553aaebdd4eea4a6bad7ea69"},"modified":"2026-05-21T16:15:00","modified_gmt":"2026-05-21T14:15:00","slug":"bausch-lomb-to-participate-in-the-goldman-sachs-47th-annual-global-healthcare-conference","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=9455","title":{"rendered":"Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference"},"content":{"rendered":"<p>VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical Officer and Head of Research and Development Yehia Hashad, MD, will participate in a fireside chat at the Goldman Sachs 47<sup>th<\/sup> Annual Global Healthcare Conference in Miami, FL, on Tuesday, June 9, 2026, at 1:20 p.m. ET.<\/p><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521880265\/en\/1668940\/5\/Bausch_Lomb_logo.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521880265\/en\/1668940\/22\/Bausch_Lomb_logo.jpg\" \/><\/a><br\/><a href=\"https:\/\/mms.businesswire.com\/media\/20260521880265\/en\/1668940\/5\/Bausch_Lomb_logo.jpg\"><img src=\"https:\/\/mms.businesswire.com\/media\/20260521880265\/en\/1668940\/21\/Bausch_Lomb_logo.jpg\" \/><\/a><p>\nA live webcast of the session will be available on the <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.bausch.com%2Finvestors%2Fevents-presentations&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=1&amp;md5=4791ec6316107d2807322dbdf4fc2913\" rel=\"nofollow\" shape=\"rect\">Investor Relations<\/a> section of the Bausch + Lomb website.<\/p><p>\n<b>About Bausch + Lomb\n<br\/><\/b>Our mission is simple \u2013 we help people see better to live better, all over the world. For nearly two centuries we\u2019ve evolved with the changing needs of patients and customers, and our commitment to innovation and improving the standard of care in eye health has never been stronger. From contact lenses to prescription products, over-the-counter options, surgical devices and more, we\u2019re turning bold ideas into better outcomes through passion, perseverance and purpose. Learn more at <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.bausch.com%2F&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=www.bausch.com&amp;index=2&amp;md5=798435a3110bca1340c9a526261200cc\" rel=\"nofollow\" shape=\"rect\">www.bausch.com<\/a> and connect with us on <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FBauschandLomb&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=Facebook&amp;index=3&amp;md5=5d861108b714c5db1e7518e2fccf7a1b\" rel=\"nofollow\" shape=\"rect\">Facebook<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fbauschlomb%2F%3Fhl%3Den&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=Instagram&amp;index=4&amp;md5=e2655f838046601154e0deb6170b2a53\" rel=\"nofollow\" shape=\"rect\">Instagram<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2F5185%2Fadmin%2F&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=5&amp;md5=8ee25dff1b90bff32c2030379dea4320\" rel=\"nofollow\" shape=\"rect\">LinkedIn<\/a>, <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fx.com%2FBauschLomb&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=X&amp;index=6&amp;md5=07e11d39251c403aacb2b44963b19023\" rel=\"nofollow\" shape=\"rect\">X<\/a> and <a  href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.youtube.com%2Fbauschlomb1&amp;esheet=54539605&amp;newsitemid=20260521880265&amp;lan=en-US&amp;anchor=YouTube&amp;index=7&amp;md5=d0ba6de969a05640132412ecb1f9930a\" rel=\"nofollow\" shape=\"rect\">YouTube<\/a>.<\/p><p>\n<i><sup>\u00a9<\/sup> 2026 Bausch + Lomb<\/i><\/p><br\/> <b>Contacts<\/b> <br\/><p>\n<b>Media Contact:\n<br\/><\/b>Chris Clark\n<br\/><a  href=\"mailto:chris.clark@bausch.com\" rel=\"nofollow\" shape=\"rect\">chris.clark@bausch.com<\/a><br\/>(848) 360-1100<\/p><p>\n<b>Investor Contact:<\/b><br\/>George Gadkowski\n<br\/><a  href=\"mailto:george.gadkowski@bausch.com\" rel=\"nofollow\" shape=\"rect\">george.gadkowski@bausch.com<\/a><br\/>(877) 354-3705 (toll free)\n<br\/>(908) 927-0735<\/p>","protected":false},"excerpt":{"rendered":"<p>VAUGHAN, Ontario&#8211;(BUSINESS WIRE)&#8211;Bausch + Lomb Corporation (NYSE\/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical Officer and&#8230;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-9455","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9455","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9455"}],"version-history":[{"count":1,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9455\/revisions"}],"predecessor-version":[{"id":9456,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/9455\/revisions\/9456"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9455"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9455"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9455"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}